In a separate investigation, genetically proxied inhibition of IL-6 signaling further associated with reduced risk of ‘stroke of undetermined source’.100 These findings implicate IL-6 signaling in the pathogenesis of multiple stroke subtypes and cardiovascular disease, a hypothesis that is under active investigation in phase 3 clinical trials (Table 3). The gene discussed is IL6; the disease is Stroke.